Honglei Jiang

650 total citations
27 papers, 522 citations indexed

About

Honglei Jiang is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Honglei Jiang has authored 27 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Molecular Biology and 7 papers in Surgery. Recurrent topics in Honglei Jiang's work include Immunotherapy and Immune Responses (4 papers), Cancer-related Molecular Pathways (4 papers) and Enhanced Recovery After Surgery (2 papers). Honglei Jiang is often cited by papers focused on Immunotherapy and Immune Responses (4 papers), Cancer-related Molecular Pathways (4 papers) and Enhanced Recovery After Surgery (2 papers). Honglei Jiang collaborates with scholars based in China. Honglei Jiang's co-authors include Junzhe Jin, Zhe‐Ming Zhao, Hao Yu, Chun‐Dong Zhang, Dong Xu, Guofu Lin, Dong Xu, Qing Liu, Dong Xu and Xu Ma and has published in prestigious journals such as International Journal of Molecular Sciences, Carbohydrate Polymers and International Journal of Biological Macromolecules.

In The Last Decade

Honglei Jiang

26 papers receiving 508 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Honglei Jiang China 12 254 117 87 82 58 27 522
Xinxing Li China 15 264 1.0× 92 0.8× 91 1.0× 141 1.7× 53 0.9× 31 561
Hongping Wang China 13 251 1.0× 106 0.9× 62 0.7× 51 0.6× 97 1.7× 43 517
Weiming He China 13 285 1.1× 115 1.0× 67 0.8× 49 0.6× 46 0.8× 46 663
Ting Jiang China 13 271 1.1× 84 0.7× 112 1.3× 63 0.8× 81 1.4× 30 673
Masayoshi Fujisawa Japan 12 358 1.4× 111 0.9× 92 1.1× 105 1.3× 47 0.8× 53 751
Young‐Joo Jeon South Korea 16 343 1.4× 92 0.8× 68 0.8× 71 0.9× 46 0.8× 36 609

Countries citing papers authored by Honglei Jiang

Since Specialization
Citations

This map shows the geographic impact of Honglei Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Honglei Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Honglei Jiang more than expected).

Fields of papers citing papers by Honglei Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Honglei Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Honglei Jiang. The network helps show where Honglei Jiang may publish in the future.

Co-authorship network of co-authors of Honglei Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Honglei Jiang. A scholar is included among the top collaborators of Honglei Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Honglei Jiang. Honglei Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yan, Zu‐Yi Li, Honglei Jiang, et al.. (2024). Preparation and immunological activity evaluation of an intranasal protein subunit vaccine against ancestral and mutant SARS-CoV-2 with curdlan sulfate/O-linked quaternized chitosan nanoparticles as carrier and adjuvant. International Journal of Biological Macromolecules. 276(Pt 1). 133733–133733. 4 indexed citations
2.
Lu, Lu, et al.. (2023). Transcytosable Peptide-Paclitaxel Prodrug Nanoparticle for Targeted Treatment of Triple-Negative Breast Cancer. International Journal of Molecular Sciences. 24(5). 4646–4646. 18 indexed citations
3.
Zhang, Yu, et al.. (2022). PRELP promotes myocardial fibrosis and ventricular remodelling after acute myocardial infarction by the wnt/β–catenin signalling pathway. Cardiovascular journal of South Africa. 33(5). 6–11. 10 indexed citations
4.
Jiang, Honglei, et al.. (2019). Curdlan sulfate/O-linked quaternized chitosan nanoparticles acting as potential adjuvants promote multiple arms of immune responses. Carbohydrate Polymers. 213. 100–111. 28 indexed citations
5.
Jiang, Honglei, Dan Wu, Dong Xu, et al.. (2017). Eupafolin Exhibits Potent Anti-Angiogenic and Antitumor Activity in Hepatocellular Carcinoma. International Journal of Biological Sciences. 13(6). 701–711. 24 indexed citations
6.
Xu, Dong, Junzhe Jin, Hao Yu, et al.. (2017). Chrysin inhibited tumor glycolysis and induced apoptosis in hepatocellular carcinoma by targeting hexokinase-2. Journal of Experimental & Clinical Cancer Research. 36(1). 44–44. 144 indexed citations
7.
Liu, Qing, Li Ding, Honglei Jiang, Chun‐Dong Zhang, & Junzhe Jin. (2017). Efficacy of fast track surgery in laparoscopic radical gastrectomy for gastric cancer:a meta-analysis of randomized controlled trials. International Journal of Surgery. 50. 28–34. 18 indexed citations
8.
Liu, Qing, Honglei Jiang, Dong Xu, & Junzhe Jin. (2017). Effect of gum chewing on ameliorating ileus following colorectal surgery: A meta-analysis of 18 randomized controlled trials. International Journal of Surgery. 47. 107–115. 46 indexed citations
9.
Yu, Hao, Honglei Jiang, Xu D, et al.. (2016). Transcription Factor MafB Promotes Hepatocellular Carcinoma Cell Proliferation through Up-Regulation of Cyclin D1. Cellular Physiology and Biochemistry. 39(2). 700–708. 19 indexed citations
10.
Jiang, Honglei, Hao Yu, Xu Ma, et al.. (2014). MicroRNA-195 regulates steroid receptor coactivator-3 protein expression in hepatocellular carcinoma cells. Tumor Biology. 35(7). 6955–6960. 16 indexed citations
11.
Lin, Guofu, Hong Huang, Dong Xu, et al.. (2014). Capsaicin Mediates Cell Cycle Arrest and Apoptosis in Human Colon Cancer Cells via Stabilizing and Activating p53. International Journal of Biological Sciences. 10(3). 285–295. 71 indexed citations
12.
Wang, Dong, Honglei Jiang, Shuzhen Wang, et al.. (2014). Construction of tissue-engineered bone using a bioreactor and platelet-rich plasma. Experimental and Therapeutic Medicine. 8(2). 413–418. 6 indexed citations
13.
Jiang, Honglei, et al.. (2014). Levels of acylation stimulating protein and the complement component 3 precursor are associated with the occurrence and development of coronary heart disease. Experimental and Therapeutic Medicine. 8(6). 1861–1866. 12 indexed citations
14.
Wang, Dong, Guowei Wang, Ming Liu, et al.. (2014). A novel animal model of osteonecrosis of the femoral head induced using a magnetic resonance imaging-guided argon-helium cryotherapy system. Experimental and Therapeutic Medicine. 7(6). 1525–1528. 8 indexed citations
15.
Jiang, Honglei, Dong Xu, Hao Yu, et al.. (2014). DAX-1 Inhibits Hepatocellular Carcinoma Proliferation by Inhibiting β-Catenin Transcriptional Activity. Cellular Physiology and Biochemistry. 34(3). 734–742. 22 indexed citations
16.
Jiang, Honglei, et al.. (2013). Association between X-ray repair cross-complementation group 1 rs25487 polymorphism and pancreatic cancer risk. Tumor Biology. 34(6). 3417–3421. 10 indexed citations
18.
Wu, Dan, et al.. (2013). Significant association between XRCC3 C241T polymorphism and increased risk of hepatocellular carcinoma: a meta-analysis. Tumor Biology. 34(6). 3865–3869. 6 indexed citations
19.
Yang, Bo, et al.. (2012). Hamiltonian-based binocular visual servoing of camera-in-hand robotic systems. International Conference on Modelling, Identification and Control. 388–393. 1 indexed citations
20.
Jiang, Xiaofeng, Wenyu Sun, Lei Zhu, et al.. (2009). Expression of CXCR6 on CD8+ T cells was up-regulated in allograft rejection. Transplant Immunology. 22(3-4). 179–183. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026